1. Show article details.

    Baxter Named to 2019 Dow Jones Sustainability Indices

    Business Wire – 8:30 AM ET 09/16/2019

    As the DJSI World Index celebrates its 20th anniversary, Baxter is proud of recognition as a responsible corporate citizen every year since its inception Baxter International Inc. (BAX), a leading global medical products company, announced today it has again been named to the Dow Jones Sustainability Indices—the DJSI World and DJSI North America—designations Baxter has received annually since the ind...

  2. Show article details.

    Baxter Announces Acquisition of Cheetah Medical to Expand Specialized Patient Monitoring Portfolio

    Business Wire – 7:29 AM ET 09/10/2019

    DEERFIELD, Ill. The addition of Cheetah Medical will accelerate Baxter’s presence in the specialized patient monitoring space with key technology used to guide fluid management—a critical aspect of patient care—as too little or too much fluid can increase mortality and risk of complications.

  3. Show article details.

    Baxter to Host Third Quarter 2019 Financial Results Conference Call for Investors

    Business Wire – 4:15 PM ET 09/04/2019

    Baxter International Inc. (BAX), a leading global medical products company, will host a conference call to discuss its third quarter 2019 financial results on Thursday, October 24, 2019, at 7:30 a.m. Central Time. To access the call, dial 886-1929 or 239-4663.

  4. Show article details.

    Baxter Launches Olimel N12 In Europe to Meet High Protein Needs in Critically Ill Patients

    Business Wire – 5:19 AM ET 08/29/2019

    Baxter International Inc. (BAX), a global leader in clinical nutrition, announced today the European launch of Olimel N12, the new addition to the company’s olive oil-based parenteral nutrition triple-chamber bag portfolio. Olimel N12 combines a high protein formulation with low glucose content, resulting in the lowest energy to protein ratio currently available in a standardized, triple-chamber bag.

  5. Show article details.

    The Baxter International Foundation and Direct Relief Launch Program to Improve Diabetes Care in Underserved Communities

    Business Wire – 8:30 AM ET 08/21/2019

    Multi-year program begins in Greater Chicago area and will help safety-net health facilities across the United States The Baxter International Foundation, the philanthropic arm of Baxter International Inc. (BAX), and the global humanitarian organization Direct Relief announced today the launch of the Transformative Innovation Awards for Community Health: Incorporating Nutrition to Improve Diabetes He...

  6. Show article details.

    Baxter and COSMED Announce Partnership to Bring Next-generation Indirect Calorimetry Device, Q-NRG+, to Support Clinical Nutrition Globally

    Business Wire – 8:34 AM ET 08/15/2019

    DEERFIELD, Ill.

  7. Show article details.

    Baxter to Present at the Morgan Stanley 17th Annual Global Healthcare Conference

    Business Wire – 4:15 PM ET 08/14/2019

    Baxter International Inc. (BAX), a leading global medical products company, will present at the Morgan Stanley 17th Annual Global Healthcare Conference in New York on September 9, 2019. The live webcast of Baxter’s presentation can be accessed at www.baxter.com and will be available for replay through March 6, 2020.

  8. Show article details.

    Baxter to Present at the 2019 Wells Fargo Healthcare Conference

    Business Wire – 4:15 PM ET 08/13/2019

    Baxter International Inc. (BAX), a leading global medical products company, will present at the 2019 Wells Fargo Healthcare Conference in Boston on September 5, 2019. The live webcast of Baxter’s presentation can be accessed at www.baxter.com and will be available for replay through March 3, 2020.

  9. Show article details.

    Dan Loeb's hedge fund drops American Express and Constellation Brands bets, adds to Netflix stake

    MarketWatch – 3:11 PM ET 08/13/2019

    Billionaire Dan Loeb's hedge fund, Third Point LLC, disclosed that it sold off its investments in American Express Co. (AXP) and Constellation Brands Inc. (STZ) during the second quarter, while adding to its Netflix Inc. (NFLX) stake. Overall, the value of Third Point's equity holdings declined to $8.54 billion as of June 30 from $8.99 billion as of March 31; the S&P 500 rose 3.8% during the second quarter. Third Point had owned 1.5 million shares of AmEx and 1.05 million shares of Constellation Brands...

  10. Show article details.

    Georgia-based Hamilton Health Care System First in U.S. to Use New Baxter Technology in the ICU

    Business Wire – 8:07 AM ET 08/13/2019

    Hamilton Health Care System, a top 10% national hospital provider in overall health care according to CareChex® medical quality ratings, and Baxter International Inc. (BAX), a global leader in acute care, today announced that Hamilton is the first health system in the U.S. to use Baxter’s new PrisMax system. This press release features multimedia.

  11. Show article details.

    BRIEF-Third Point Dissolves Share Stake In American Express, Ups in Netflix

    Reuters – 6:34 AM ET 08/13/2019

    THIRD POINT LLC: * THIRD POINT LLC DISSOLVES SHARE STAKE IN AMERICAN EXPRESS CO - SEC FILING. * THIRD POINT LLC RAISES SHARE STAKE IN NETFLIX BY 25% TO 500,000 SHARES - SEC FILING. * THIRD POINT LLC REPORTS SHARE STAKE OF 200,500 CLASS A SHARES IN ZOOM VIDEO COMMUNICATIONS - SEC FILING. * THIRD POINT LLC TAKES SHARE STAKE OF 8 MILLION SHARES IN CLEAR CHANNEL OUTDOOR HOLDINGS - SEC FILING.

  12. Show article details.

    BRIEF-Baxter Launches Prismax In Canada To Maximize Treatment In ICU

    Reuters – 9:34 AM ET 08/12/2019

    Baxter International Inc (BAX): * BAXTER LAUNCHES PRISMAX IN CANADA TO MAXIMIZE TREATMENT IN THE INTENSIVE CARE UNIT. * BAXTER CANADA - ANNOUNCED HEALTH CANADA'S APPROVAL OF ITS PRISMAX SYSTEM AND INTEGRATED THERMAX BLOOD WARMER. * BAXTER CANADA - EXPECTS TO FILE FOR REGULATORY APPROVAL OF PRISMAX IN ADDITIONAL COUNTRIES IN 2019 AND 2020 Source text for Eikon: Further company coverage:

  13. Show article details.

    Congress seeks briefing on potential threat to U.S. heparin supply

    Reuters – 11:13 AM ET 07/30/2019

    Leaders of the U.S. House Energy and Commerce Committee on Tuesday asked the Food and Drug Administration about the potential threat to the U.S. heparin supply due to the outbreak of African swine fever in China. Heparin is currently on the FDA's drug shortage list.

  14. Show article details.

    Baxter Recognized With Highest Achievement on 2019 Diversity Best Practices Inclusion Index

    Business Wire – 9:20 AM ET 07/30/2019

    One of 14 organizations to qualify as a Top 10 Percent Inclusion Index Company Baxter International Inc. (BAX), a leading global medical products company, today announced it has been named a 2019 Top 10 Percent Inclusion Index Company, the highest-scoring category of Diversity Best Practices’ annual Inclusion Index.

  15. Show article details.

    BRIEF-Baxter International Says Supports Add-On Payment In Proposed Esrd Payment Rule

    Reuters – 8:24 AM ET 07/30/2019

    Baxter International Inc (BAX): * Baxter International Inc (BAX) - SUPPORTS ADD-ON PAYMENT IN PROPOSED ESRD PAYMENT RULE Source text for Eikon: Further company coverage:

  16. Show article details.

    Baxter Supports Add-on Payment in Proposed ESRD Payment Rule to Spur Innovation for Dialysis Patients

    Business Wire – 8:00 AM ET 07/30/2019

    Baxter International Inc. (BAX), a global innovator in renal care, today issued this statement: We support the add-on payment that is included in the End-Stage Renal Disease Prospective Payment System proposed rule released by the Centers for Medicare & Medicaid Services.

  17. Show article details.

    BRIEF-Baxter Launches Prismax In U.S. To Maximize Care For Critically Ill Patients

    Reuters – 6:10 PM ET 07/29/2019

    Baxter International Inc (BAX): * BAXTER LAUNCHES PRISMAX IN U.S. TO MAXIMIZE CARE FOR CRITICALLY ILL PATIENTS Source text for Eikon: Further company coverage:

  18. Show article details.

    Baxter Launches PrisMax in U.S. to Maximize Care for Critically Ill Patients

    Business Wire – 4:30 PM ET 07/29/2019

     . DEERFIELD, Ill. This press release features multimedia. “We looked at every detail during the PrisMax design process. Building on Baxter’s leading Prismaflex technology currently used by hospitals in more than 90 countries, the PrisMax system is used to treat patients with acute kidney injury and select autoimmune diseases.

  19. Show article details.

    Baxter Adds Finomel With Fish Oil to Ready-to-use Parenteral Nutrition Portfolio

    Business Wire – 9:18 AM ET 07/29/2019

    Baxter International Inc. (BAX), a global leader in clinical nutrition, announced today the European launch of Finomel, a ready-to-use triple-chamber bag for parenteral nutrition.

  20. Show article details.

    BRIEF-Baxter Reports Second Quarter GAAP Earnings Per Share Of $0.66

    Reuters – 7:20 AM ET 07/25/2019

    Baxter International Inc (BAX): * BAXTER REPORTS SECOND-QUARTER 2019 RESULTS. * Q2 GAAP EARNINGS PER SHARE $0.66. * Q2 EARNINGS PER SHARE ESTIMATE $0.81 -- REFINITIV IBES DATA. * SEES Q3 2019 ADJUSTED EARNINGS PER SHARE $0.82 TO $0.84 FROM CONTINUING OPERATIONS EXCLUDING ITEMS. * SEES FY 2019 ADJUSTED EARNINGS PER SHARE $3.34 TO $3.40 FROM CONTINUING OPERATIONS EXCLUDING ITEMS.

Page:

Today's and Upcoming Events

  • Oct
    24

    BAX to announce Q3 earnings (Confirmed)

Past Events (last 90 days)

  • Aug
    29

    BAX ex-Dividend for $0.22 on 08/29/2019

    • Announce Date: 07/16/2019
    • Record Date: 08/30/2019
    • Pay Date: 10/01/2019
  • Jul
    25

    BAX announced Q2 earnings.

Data provided by Thomson Reuters © 2019

Technical Events

Technical Analysis

PROVIDED BY TRADING CENTRAL
As with all your investments through Fidelity, you must make your own determination whether an investment is appropriate for you. Fidelity is not recommending or endorsing this security by making it available to customers. You should conduct research and perform a thorough investigation as to the characteristics of any securities you intend to purchase. Before investing, you should read the prospectus, offering circular, indenture, or similar document carefully for a full description of the product, including its features and risks, to determine whether it is an appropriate investment for your investment objectives, risk tolerance, financial situation and other individual factors, and be sure to re-evaluate those factors on a periodic basis.

Performance data shown represents past performance, which is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore, you may have a gain or loss when you sell your shares.


Stock markets are volatile and can decline significantly in response to adverse issuer, political, regulatory, market, or economic developments. Growth stocks can be more volatile than other types of stocks. Value stocks can continue to be undervalued by the market for long periods of time. Foreign securities are subject to interest-rate, currency-exchange-rate, economic, and political risks, all of which are magnified in emerging markets. Illiquidity is an inherent risk associated with investing in real estate and REITs. There is no guarantee the issuer of a REIT will maintain the secondary market for its shares and redemptions may be at a price which is more or less than the original price paid. Closed-end funds can trade at a discount to their NAV. Shareholders of Master Limited Partnerships may be treated as partners for tax purposes. Partnerships issue a Schedule K-1 (Form 1065) rather than a Form 1099 form for tax purposes. It lists the partner's share of income, deductions, credits, etc. Speak with your tax advisor to determine how this may affect you. A royalty trust is a type of corporation, mostly in the United States or Canada, usually involved in oil and gas production or mining. Royalty trusts may have special tax treatment, so you should consult a tax advisor on the potential tax consequences of investing in them.

News, commentary and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended for research purposes to help self-directed investors evaluate many types of securities including, but not limited to common stocks, American Depository Receipts, Master Limited Partnerships, real estate investment trusts. traditional preferred stock, trust preferred securities, third-party trust certificates, convertible securities, mandatory convertible securities and other exchange-traded equity and/or debt securities. Criteria and inputs entered, including the choice to make security comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from its use.

462499.6.0
See the Latest Features
Personalized
Get relevant information about your holdings right when you need it.
See Your Performance Click the portfolio icon to get information about stocks you own without leaving the research page.
Faster Access to Positions A shortcut to view the full list of positions in your portfolio? Yes, please! Use the ticker search box.
Add Your Own Notes Use Notebook to save your investment ideas in one convenient, private, and secure place.
Convenient For You
Research that's clear, accessible, and all in one place makes for a better experience.
One-Stop Shop See everything you need to make investment decisions right in the dashboard.
Access Anywhere No matter where you are, use the Stock Research experience across multiple devices.
New Ideas, On the Ready Find new ideas using quick links to the Stock Screener.
New Ways to Research
Discover new tools to add or diversify your existing research strategy.
StockTwits Read live tweets from the financial and investing community about the stock you're interested in.
Fundamental Analysis Save time on research by getting an overall assessment of a company's valuation, quality, growth stability, and financial health.
Recognia Technical Analysis Perfect for the technical trader—this indicator captures a stock's technical events and converts them into short, medium, and long-term sentiment.
Top Competitors See how a stock measures up by instantly comparing it to the industry average and its top four competitors.
Social Sentiment Get a sense of people's overall feelings towards a company in social media with this summary tool.
Earnings Data Monitor earnings expectations over the past three quarters and model a stock's price based on its P/E.